Trinity Biotech plc
TRIB
$0.35
$0.012.28%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 11.07M | 10.83M | 15.86M | 15.15M | 15.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.07M | 10.83M | 15.86M | 15.15M | 15.70M |
| Cost of Revenue | 7.17M | 6.22M | 10.98M | 9.84M | 15.38M |
| Gross Profit | 3.90M | 4.61M | 4.88M | 5.31M | 329.00K |
| SG&A Expenses | 5.79M | 6.98M | 8.37M | 6.52M | 5.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.84M | -- | 1.83M | -- | -1.00K |
| Total Operating Expenses | 12.18M | 13.83M | 22.63M | 17.37M | 21.55M |
| Operating Income | -1.11M | -3.00M | -6.78M | -2.22M | -5.84M |
| Income Before Tax | -17.65M | -5.67M | -15.80M | -4.79M | -9.99M |
| Income Tax Expenses | -174.00K | 294.00K | 585.00K | -35.00K | 2.00K |
| Earnings from Continuing Operations | -17.48M | -5.97M | -16.38M | -4.76M | -9.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 1.04M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.48M | -5.97M | -16.96M | -4.76M | -8.95M |
| EBIT | -1.11M | -3.00M | -6.78M | -2.22M | -5.84M |
| EBITDA | -779.30K | -2.35M | -7.54M | -1.62M | -5.10M |
| EPS Basic | -18.68 | -6.40 | -4.43 | -9.16 | -23.47 |
| Normalized Basic EPS | -0.13 | -0.17 | -- | -- | -- |
| EPS Diluted | -19.90 | -8.00 | -8.64 | -9.16 | -23.60 |
| Normalized Diluted EPS | -0.13 | -0.17 | -- | -- | -- |
| Average Basic Shares Outstanding | 18.71M | 18.63M | 17.96M | 10.39M | 7.62M |
| Average Diluted Shares Outstanding | 935.50K | 931.60K | 897.90K | 519.30K | 381.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |